# The urgent need for African research collaboration on medicine quality

**Authors:** Fanqi Zeng, Simon Mariwah, Gerry Mshana, Daniel Amoako-Sakyi, Heather Hamill

PMC · DOI: 10.1038/s41467-025-67430-z · Nature Communications · 2026-01-10

## TL;DR

The paper highlights the urgent need for African research collaboration to address the problem of poor-quality medicines in Africa.

## Contribution

The paper emphasizes the need for African-led research to combat substandard and falsified medicines.

## Key findings

- Research on substandard and falsified medicines in Africa is fragmented and led by Global North institutions.
- Building African-led research capacity is crucial for developing evidence-based policies to address the issue.

## Abstract

Substandard and falsified medicines threaten African health systems, yet research on this crisis is fragmented and concentrated in few countries, predominantly led by Global North institutions. Building African-led research capacity is essential for evidence-based policy.

Substandard and falsified medicines are a global health threat. The fight against them is a regulatory and research challenge; here, the authors argue the importance of global and regional oversight, monitoring of, and research into the extent of the issue.

## Full-text entities

- **Diseases:** Infectious Diseases (MESH:D003141), deaths (MESH:D003643), COVID-19 (MESH:D000086382)
- **Chemicals:** SF (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12800327/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12800327/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12800327/full.md

---
Source: https://tomesphere.com/paper/PMC12800327